Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology “Ignacio Chávez”
作者: Kyla JonesJocelyn RamirezManny PapadimitropoulosOscar S. LomelíHéctor Roque VanegasEvelyn Cortina de la RosaRaúl Izaguirre Ávila
作者单位: 1T. I. Salud, Mexico D.F., Mexico
2Eli Lilly Mexico, Mexico D.F., Mexico
3Eli Lilly & Company and University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, Ontario, Canada
4Department of Hematology, National Institute of Cardiology “Ignacio Chávez”, Mexico D.F., Mexico
刊名: Value in Health Regional Issues, 2019, Vol.20 , pp.136-141
来源数据库: Elsevier Journal
DOI: 10.1016/j.vhri.2019.02.007
关键词: ACSCostingHospitalMexicoPCI
英文摘要: Abstract(#br)Background(#br)The treatment of acute coronary syndrome (ACS) using percutaneous coronary intervention (PCI) is a frequent intervention with a high economic impact.(#br)Objective(#br)This study investigates the resource use and cost of PCI in Mexico where heart disease is a leading cause of death, and a large segment of the population does not have formal healthcare coverage.(#br)Methods(#br)This retrospective observational study obtained resource utilization data from patient files and itemized costs from the pharmacy registry at the National Institute of Cardiology. Patients were aged >18 years, diagnosed with ACS, and treated with PCI and secondary prophylaxis with aspirin plus clopidogrel or prasugrel. Patients had a follow-up of >12 months at the institute. Statistical...
全文获取路径: Elsevier  (合作)

  • National 国民牌大客车